Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
December 13, 2017
Women In Bio Holds First Annual Boardroom Ready Reception & Retreat for 2016/2017 Alumni in New York
BOSTON, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Women In Bio (WIB) an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life ...
December 13, 2017
Windtree Therapeutics to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018
WARRINGTON, Pa., Dec. 12, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that its ...
December 13, 2017
MiMedx Forecasts 2018 Revenue To Be In The Range Of $383 Million To $387 Million
MARIETTA, Ga., Dec. 13, 2017 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with ...
December 13, 2017
DURECT Announces NDA Acceptance of Indivior's RBP-7000 Risperidone Monthly Depot
CUPERTINO, Calif., Dec. 13, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today announced that Indivior PLC (INDV.L) has reported that the U.S. Food and Drug Administration (FDA) has accepted ...
December 13, 2017
ESSA Pharma Announces Pricing of Previously Announced Equity Offering
HOUSTON and VANCOUVER , Dec. 13, 2017 /CNW/ - ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce today ...
December 12, 2017
Windtree Therapeutics to Participate in Corporate Access Event in San Francisco, January 8 - 10, 2018
WARRINGTON, Pa., Dec. 12, 2017 /PRNewswire/ -- Windtree Therapeutics, Inc. (WINT), a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that its ...
December 12, 2017
Brainsway Raises $8.5 Million From Leading Israeli Investors
Brainsway Ltd. (TASE: BRIN), a leading developer of breakthrough brain disorder treatment technology, is pleased to announce that it has completed an $8.5 million equity ...
December 12, 2017
MiMedx Announces Release Of 2018 Guidance And Shareholder Conference Call
MARIETTA, Ga., Dec. 12, 2017 /PRNewswire/ -- MiMedx Group, Inc. (MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and ...
December 12, 2017
ESSA Pharma Announces Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2017
HOUSTON and VANCOUVER, Dec. 11, 2017 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for prostate cancer, ...
December 12, 2017
Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer
NASHUA, N.H., Dec. 12, 2017 (GLOBE NEWSWIRE) --  iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ...
December 12, 2017
Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15
Ohr Pharmaceutical, Inc. (OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report financial results for its fiscal ...
December 12, 2017
VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI) today announced that Jeff Baxter, President and CEO, will present at ...
December 12, 2017
Soleno Therapeutics Announces $15 Million Private Placement
REDWOOD CITY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
December 12, 2017
Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic® in Peru
WIXOM, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), announced today that it has signed an exclusive license and manufacturing supply agreement ...
December 12, 2017
UroGen Pharma Expands Clinical Development Leadership Team
RA'ANANA, Israel and NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) --  UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in ...
December 12, 2017
Acer Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
NEWTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
December 11, 2017
Minerva Neurosciences Names Richard Russell President
WALTHAM, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
December 11, 2017
Aptose Presents New Preclinical Data on CG’806 pan-FLT3/pan-BTK Inhibitor at ASH 59th Annual Meeting
SAN DIEGO and TORONTO, Dec. 11, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO) today announced the presentation of preclinical data from research led ...
December 11, 2017
Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round
JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to ...
December 11, 2017
Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
NEWTON, Mass., Dec. 11, 2017 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
Page 124 of 169